Article Text

Download PDFPDF
Musical hallucinations: a rare and atypical presentation of anti-IgLON5 disease responsive to immunosuppressive therapy
  1. Alex Stoyanov1,
  2. Alan McDougall2 and
  3. Nicolas Urriola1
  1. 1Department of Clinical Immunology, Liverpool Hospital, Liverpool, New South Wales, Australia
  2. 2Neurology Department, Liverpool Hospital, Liverpool, New South Wales, Australia
  1. Correspondence to Dr Alex Stoyanov; alex.stoyanov{at}health.nsw.gov.au

Abstract

IgLON5 antibodies are typically associated with the insidious onset of sleep disorder, parasomnia, gait disturbance and abnormal movements, with variable response to immunosuppressive therapy. We describe a case of a 50-year-old man who presented with acute speech difficulties, headache and focal seizures followed by well-formed visual hallucinations, and later, musical hallucinations of mainstream popular music. MRI of the brain demonstrated right temporal lobe changes with corresponding epileptiform activity seen on electroencephalogram. Subsequently, IgLON5 antibodies were detected in the serum. The patient was treated with anticonvulsants, as well as azathioprine with a tapering oral prednisone course with a complete resolution of the symptoms. Our case demonstrates an unusual presentation of the rare but increasingly described anti-IgLON5 disease, with musical hallucinations. The case highlights the variable and evolving clinical phenotypes that can be seen in autoimmune central nervous system disorders.

  • immunology
  • neurology

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors AS contributed to the compilation of patient history, data collection and drafting of the manuscript for intellectual content; AM contributed to the compilation of patient history and data collection; NU contributed to the compilation of patient history, data collection and revised the manuscript for intellectual content. All authors read the final manuscript and approved its submission.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.